Combinable.AI Ltd.

combinableai.com

Now Insitro Israel

High-Tech Company

Acquired by Insitro

TECH VERTICALS

Drug Discovery Antibodies, Artificial Intelligence, Biotechnology, Computational Biology, Life Sciences, Machine Learning, MedTech, Optimization, Precision Medicine, Vertical AI

General Data

Sector	Biomed
Company Stage:	R&D
Established	2023
Number of Employees	7

DESCRIPTION

CombinAbleAI is an AI-driven biotechnology company developing an in silico platform to design and optimize therapeutic antibodies. The company applies advanced machine learning and computational molecular simulation to accelerate antibody discovery and engineering. By enabling multi-parameter optimization across key developability and efficacy attributes, CombinAbleAI aims to reduce trial and error, shorten development timelines, and improve the quality of drug candidates advancing toward the clinic.

TECHNOLOGY

AI-driven in silico platform for therapeutic antibody design and optimization, incorporating physics-informed models, molecular dynamics simulation, and multimodal machine learning.

	TARGET MARKETS
	Biopharmaceutical companies, Therapeutic antibody developers in oncology, immunology, infectious disease, and other therapeutic areas.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Rehovot, Israel

Address	4 Oppenheimer St., Ogen B Building, 17th Floor
City	Rehovot
Country	Israel
Zip	7670104

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Noam Katz	Co-Founder
Dr. Daria Kokh	Co-Founder

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Jan. 12, 2026

R&D

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors